<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01331330</url>
  </required_header>
  <id_info>
    <org_study_id>NM-09-035-EU-DB</org_study_id>
    <nct_id>NCT01331330</nct_id>
  </id_info>
  <brief_title>European Deep Brain Stimulation (DBS) Depression Study</brief_title>
  <official_title>A Clinical Evaluation of Different Device Parameters for the Management of Patients With Treatment Resistant Major Depressive Disorder, Single or Recurrent Episode, With Deep Brain Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <brief_summary>
    <textblock>
      To evaluate the effects of two different programming settings of deep brain stimulation (DBS)
      in the subgenual white matter (Brodmann Area 25 WM) as an adjunctive treatment for TR-MDD,
      single or recurrent episode on mood as measured by the MADRS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of change from mean baseline values in MADRS score</measure>
    <time_frame>6 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of change from baseline value of HDRS</measure>
    <time_frame>3, 6, 9, and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Depressive Disorder, Major</condition>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low Programming</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal Programming</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Normal DBS Programming</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>Libra Deep Brain Stimulation System (St. Jude Medical Neuromodulation Division)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep Brain Stimulation</intervention_name>
    <description>Low Programming</description>
    <arm_group_label>Group B</arm_group_label>
    <other_name>Libra Deep Brain Stimulation System(St. Jude Medical Neuromodulation Division)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women (non-pregnant) age is 21-70 years;

          -  Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by
             DSM-IV-TR criteria derived from the MINI;

          -  First episode onset before age 45;

          -  Current episode &gt; 12 month duration;

          -  In the current episode: Documented resistance to a minimum of 4 adequate depression
             treatments from at least 3 different categories;

          -  In adult lifetime (&gt;21 year of age) have experience a period of wellness as defined by
             DSM IV criteria;

          -  MADRS score ≥22 at 2 separate baseline visits, rated by 2 separate psychiatrists;

          -  GAF score &lt;50;

          -  Mini-mental state examination (MMSE) score &gt;24;

          -  No change in current antidepressant medication regimen or medication free for at least
             4 weeks prior to study entry;

          -  Able to give informed consent in accordance with institutional policies;

        Exclusion Criteria:

          -  A diagnosis of bipolar I or bipolar II disorder by DSM-IV-TR criteria, derived from
             the MINI;

          -  Meets criteria for borderline or antisocial personality disorder in the last 12 months
             by DSM-IV-TR criteria, derived from the Cluster B Personality Disorders Sections 301.7
             - 301.83, preferably screened via SCID-II at Baseline visit (optional);

          -  In the current depressive episode, has been diagnosed with General Anxiety Disorder
             (GAD) - as defined by the DSM-IV-TR, and GAD is the primary diagnosis;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DeLea Peichel</last_name>
    <role>Study Director</role>
    <affiliation>St. Jude Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital La Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah-Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College London</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital for Neurology and Neurosurgery - UCL</name>
      <address>
        <city>London</city>
        <zip>WC1N 3</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Israel</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Germany</country>
  </removed_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2011</study_first_submitted>
  <study_first_submitted_qc>April 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2011</study_first_posted>
  <last_update_submitted>May 18, 2015</last_update_submitted>
  <last_update_submitted_qc>May 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Depressive Disorder</keyword>
  <keyword>Unipolar</keyword>
  <keyword>Implantable Stimulation Electrodes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>February 22, 2017</submitted>
    <returned>April 6, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

